Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) October 25 – 27, 2024!

For more Information and Register: Delaware ACC By the Sea: 2024 Chapter Meeting

Delaware Chapter of the American College of Cardiology


Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • ACC.25 Science Explores Plant-Based Diets and Mortality, Sex Differences in CV Health, New Wearables Metric, and More
    Studies being presented at ACC.25 later this week in Chicago, IL, will explore the association between plant-based diets and mortality in patients with cardiometabolic diseases, sex differences in cardiovascular health status and long-term outcomes, a new wearables metric related to cardiovascular disease and much more.
  • Explore NCDR Research at ACC.25
    Several abstracts using data from the NCDR suite of registries will be featured at ACC.25, taking place March 29-31 in Chicago, IL. Explore how investigators leverage NCDR data to test their hypotheses on patient risk factors and outcomes, procedure and treatment trends, diversity, health equity and inclusion, guideline adherence, device, facility and provider characteristics, and […]
  • Withdrawing GDMT in Patients With HF and Improved LVEF Increases Mortality/Morbidity
    In patients with heart failure and improved ejection fraction (HFimpEF), withdrawing vs. continuing guideline-directed medical therapy (GDMT) with renin-angiotensin inhibitors (RASi)/angiotensin receptor–neprilysin inhibitors (ARNi) and mineralocorticoid receptor antagonists (MRA), but not beta-blockers (BB), is significantly associated with worse survival and morbidity at one year...
  • Feature | Making A Global Difference: Navin C. Nanda, MD, FACC
    Beginning in 2026, the ACC's Distinguished Award for International Service will be named in honor of Navin C. Nanda, MD, FACC, thanks to the support of the American Association of Cardiologists of Indian Origin (AACIO).
  • Feature | Driving Change, Building Community: How ACC Chapters Shape the ACC Experience
    ACC Chapters are instrumental in driving action at the state level and are at the forefront of helping to deliver on the College's Mission to transform cardiovascular care and improve heart health for all.